380 related articles for article (PubMed ID: 31419911)
1. Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary Fibrosis.
Park JK; Coffey NJ; Bodine SP; Zawatsky CN; Jay L; Gahl WA; Kunos G; Gochuico BR; Malicdan MCV; Cinar R
Am J Respir Cell Mol Biol; 2020 Feb; 62(2):178-190. PubMed ID: 31419911
[TBL] [Abstract][Full Text] [Related]
2. Peripheral Hybrid CB
Zawatsky CN; Park JK; Abdalla J; Kunos G; Iyer MR; Cinar R
Front Endocrinol (Lausanne); 2021; 12():744857. PubMed ID: 34650521
[TBL] [Abstract][Full Text] [Related]
3. Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice.
Pan L; Cheng Y; Yang W; Wu X; Zhu H; Hu M; Zhang Y; Zhang M
Inflammation; 2023 Aug; 46(4):1531-1542. PubMed ID: 37160579
[TBL] [Abstract][Full Text] [Related]
4. Nintedanib Reduces Neutrophil Chemotaxis via Activating GRK2 in Bleomycin-Induced Pulmonary Fibrosis.
Chen WC; Chen NJ; Chen HP; Yu WK; Su VY; Chen H; Wu HH; Yang KY
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630825
[TBL] [Abstract][Full Text] [Related]
5. Nintedanib Inhibits Endothelial Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis via Focal Adhesion Kinase Activity Reduction.
Yu WK; Chen WC; Su VY; Shen HC; Wu HH; Chen H; Yang KY
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897764
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary fibrosis model of mice induced by different administration methods of bleomycin.
Gul A; Yang F; Xie C; Du W; Mohammadtursun N; Wang B; Le J; Dong J
BMC Pulm Med; 2023 Mar; 23(1):91. PubMed ID: 36944966
[TBL] [Abstract][Full Text] [Related]
7. Fyn-kinase and caveolin-1 in the alveolar epithelial junctional adherence complex contribute to the early stages of pulmonary fibrosis.
Menzel V; Ziegler M; Hante N; Sake JA; Santos-Martinez MJ; Ehrhardt C; Kasper M; Barth K
Eur J Pharm Sci; 2022 Aug; 175():106236. PubMed ID: 35710078
[TBL] [Abstract][Full Text] [Related]
8. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
9. Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis.
Günther S; Bordenave J; Hua-Huy T; Nicco C; Cumont A; Thuillet R; Tu L; Quatremarre T; Guilbert T; Jalce G; Batteux F; Humbert M; Savale L; Guignabert C; Dinh-Xuan AT
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567353
[TBL] [Abstract][Full Text] [Related]
10. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis.
Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP
J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252
[TBL] [Abstract][Full Text] [Related]
11. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
[TBL] [Abstract][Full Text] [Related]
12. A mouse model of progressive lung fibrosis with cutaneous involvement induced by a combination of oropharyngeal and osmotic minipump bleomycin delivery.
Grandi A; Ferrini E; Zoboli M; Buseghin D; Pennati F; Khalajzeyqami Z; Ciccimarra R; Villetti G; Stellari FF
Am J Physiol Lung Cell Mol Physiol; 2024 Jun; 326(6):L736-L753. PubMed ID: 38651940
[TBL] [Abstract][Full Text] [Related]
13. Selenite selectively kills lung fibroblasts to treat bleomycin-induced pulmonary fibrosis.
Lin JH; Liu CC; Liu CY; Hsu TW; Yeh YC; How CK; Hsu HS; Hung SC
Redox Biol; 2024 Jun; 72():103148. PubMed ID: 38603946
[TBL] [Abstract][Full Text] [Related]
14. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
[TBL] [Abstract][Full Text] [Related]
15. A novel segmental challenge model for bleomycin-induced pulmonary fibrosis in sheep.
Organ L; Bacci B; Koumoundouros E; Barcham G; Kimpton W; Nowell CJ; Samuel C; Snibson K
Exp Lung Res; 2015 Apr; 41(3):115-34. PubMed ID: 25531791
[TBL] [Abstract][Full Text] [Related]
16. Aucuparin Suppresses Bleomycin-Induced Pulmonary Fibrosis Via Anti-Inflammatory Activity.
Lee SY; Park SY; Lee GE; Kim H; Kwon JH; Kim MJ; Yoon HG
J Med Food; 2021 Feb; 24(2):151-160. PubMed ID: 33512266
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1-derived peptide limits development of pulmonary fibrosis.
Marudamuthu AS; Bhandary YP; Fan L; Radhakrishnan V; MacKenzie B; Maier E; Shetty SK; Nagaraja MR; Gopu V; Tiwari N; Zhang Y; Watts AB; Williams RO; Criner GJ; Bolla S; Marchetti N; Idell S; Shetty S
Sci Transl Med; 2019 Dec; 11(522):. PubMed ID: 31826982
[TBL] [Abstract][Full Text] [Related]
18. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis.
Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE
Am J Physiol Lung Cell Mol Physiol; 2010 Oct; 299(4):L442-52. PubMed ID: 20562227
[TBL] [Abstract][Full Text] [Related]
19. Pirfenidone and nintedanib exert additive antifibrotic effects by the SPP1-AKT pathway in macrophages and fibroblasts.
Meng C; Fan G; Liu J; Tao N; Sun T
Biochem Biophys Res Commun; 2024 Jul; 716():150020. PubMed ID: 38692011
[TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.
Williamson JD; Sadofsky LR; Hart SP
Exp Lung Res; 2015 Mar; 41(2):57-73. PubMed ID: 25514507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
